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Introduction: Restrictions on existing APOE mouse models have impacted research
toward understanding the strongest genetic risk factor contributing to Alzheimer’s
disease (AD) and dementia, APOEε4 , by hindering observation of a key, common
genotype in humans – APOEε3/ε4 . Human studies are typically underpowered to
address APOEε4 allele risk as the APOEε4/ε4 genotype is rare, which leaves human
and mouse research unsupported to evaluate the APOEε3/ε4 genotype on molecular
and pathological risk for AD and dementia.
Methods: As a part of MODEL-AD, we created and validated new versions of
humanized APOEε3/ε3 and APOEε4/ε4 mouse strains that, due to unrestricted breeding,
allow for the evaluation of the APOEε3/ε4 genotype. As biometric measures are often
translatable between mouse and human, we profiled circulating lipid concentrations.
We also performed transcriptional profiling of the cerebral cortex at 2 and 4 months
(mos), comparing APOEε3/ε4 and APOEε4/ε4 to the reference APOEε3/ε3 using
linear modeling and WGCNA. Further, APOE mice were exercised and compared to
litter-matched sedentary controls, to evaluate the interaction between APOEε4 and
exercise at a young age.
Results: Expression of human APOE isoforms were confirmed in APOEε3/ε3 ,
APOEε3/ε4 and APOEε4/ε4 mouse brains. At two mos, cholesterol composition was
influenced by sex, but not APOE genotype. Results show that the APOEε3/ε4 and
APOEε4/ε4 genotype exert differential effects on cortical gene expression. APOEε3/ε4
uniquely impacts ‘hormone regulation’ and ‘insulin signaling,’ terms absent in APOEε4/ε4
data. At four mos, cholesterol and triglyceride levels were affected by sex and activity,
with only triglyceride levels influenced by APOE genotype. Linear modeling revealed
APOEε3/ε4 , but not APOEε4/ε4 , affected ‘extracellular matrix’ and ‘blood coagulation’
related terms. We confirmed these results using WGCNA, indicating robust, yet subtle,
transcriptional patterns. While there was little evidence of APOE genotype by exercise
interaction on the cortical transcriptome at this young age, running was predicted to
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affect myelination and gliogenesis, independent of APOE genotype with few APOE
genotype-specific affects identified.
Discussion: APOEε4 allele dosage-specific effects were observed in circulating lipid
levels and cortical transcriptional profiles. Future studies are needed to establish how
these data may contribute to therapeutic development in APOEε3/ε4 and APOEε4/ε4
dementia patients.
Keywords: APOE4 and APOE3, APOE4 and AD risk, transcriptome (RNA-seq), exercise, Alzheimer’s disease,
dementia - Alzheimer’s disease, dementia, cerebral cortex

INTRODUCTION

region and receptor binding region differ in affinity to its
respective receptors between APOEε2 , APOEε3 , and APOEε4 .
Cerebral APOE is produced mainly by astrocytes, however during
stress can be upregulated and produced by microglia and possibly
neurons (Chan et al., 1989; Hauser et al., 2011; Chernick et al.,
2019). Studies have utilized humanized APOE mouse models
crossed with amyloid and tau mouse models to show that, in
addition to lipid trafficking, APOE functions in a variety of ADrelevant processes including amyloid clearance and tau-mediated
neurodegeneration (Sullivan et al., 1997; Knouff et al., 1999;
Huang et al., 2017; Liu et al., 2017; Shi et al., 2017; Huynh et al.,
2019). However, these studies assessed homozygous APOEε3/ε3
and APOEε4/ε4 , but not the heterozygous APOEε3/ε4 genotype.
Human and murine studies have parsed out important
mechanisms by which the APOEε4 allele differs in comparison to
the APOEε3 allele to increase detrimental brain pathology leading
to AD and other dementias. However, little is known about
the mechanisms by which APOEε3 and APOEε4 may interact in
those with the APOEε3/ε4 genotype to affect risk for dementia.
This lack of knowledge has been in part due to legal restrictions
on the breeding of APOEε4/ε4 to APOEε3/ε3 mice to create
APOEε3/ε4 mice. This limitation has also meant that experiments
comparing APOEε3/ε3 to APOEε4/ε4 were often not performed
in litter-matched mice. It has been shown that the APOEε4
isoform is degraded at a higher rate by astrocytes compared to
the APOEε3 isoform (Ramaswamy et al., 2005; Riedel et al., 2016).
Others have shown differential bioenergetics in male APOEε3/ε4
mice compared to male APOEε3/ε3 mice (Area-Gomez et al.,
2020). Nonetheless, much is still to be learned about the global
consequences of the APOEε3/ε4 genotype. It is conceivable there
may be compensatory, dominant, or APOEε4 dose-dependent
effects on molecular changes predisposing risk for ADRDs.
To improve translatability of APOE mouse models to enable
new discoveries for human biology, here we describe the creation
of a new set of humanized APOE mouse models, using a similar
design to models commonly used (Sullivan et al., 1997; Knouff
et al., 1999). There are no breeding or distribution restrictions
on these new humanized APOE models. Further, we used our
new humanized APOE mouse models to test our hypothesis
that APOEε3/ε4 mice show characteristics that may modify risk
for dementias that are distinct from APOEε4/ε4 mice. First, we
assessed male and female APOE mice, examining the effects of
sex and APOEε4 at 2 months (2 mos) of age. We next evaluated
a cohort at 4 months (4 mos) which also including a running
cohort to evaluate the potential interactions between APOEε4

The ε4 allele of apolipoprotein E (APOE), APOEε4 , has been
identified as one of the greatest genetic risk factors for Alzheimer’s
disease (AD) and related dementias (ADRDs) (Rohn, 2014;
Halliday et al., 2016; Riedel et al., 2016; Koizumi et al., 2018;
Zhao et al., 2020). The ε3 and ε2 alleles of APOE confer neutral
and protective risk, respectively. In late-onset AD (LOAD),
allele frequencies vary between cases and controls, with APOEε2 ,
APOEε3 , and APOEε4 present at a rate of 8%, 78%, and
14%, respectively, in unaffected subjects, and 4%, 59% and
37%, respectively, in affected subjects (Farrer et al., 1997). The
frequency of LOAD increases from 20% in a non-carrier of
APOEε4 , to 47% when carrying one copy, and up to 91%
when carrying two copies (Bell et al., 2012). In VaD, APOEε4
predisposes individuals for increased risk of cerebrovascular
disease and ischemic stroke, potentially up to 30% (Belloy et al.,
2019). With APOEε4 being less frequent than APOEε3 , the more
common risk genotype in at risk populations is APOEε3/ε4 ,
with 41.1% of LOAD cases possessing the APOEε3/ε4 genotype
compared to 14.8% with APOEε4/ε4 (Farrer et al., 1997).
Genetic variation between mouse strain Apoe has been
proposed to modify phenotypes relevant to human aging and
dementia (Neuner et al., 2019). However, mouse strains do
not carry equivalent Apoe alleles to those observed in humans.
Therefore, humanized APOE mice have contributed greatly
to what we currently understand about the myriad of APOE
mechanisms that may contribute risk for dementia. APOEε4
is predicted to increase risk for multiple dementias through
either gain of toxic function or loss of function which is
context dependent (Belloy et al., 2019). Additionally, it is well
understood that there are at least two major compartments by
which APOE functions –peripherally (i.e., blood) and centrally
(i.e., brain) (Chan et al., 1989; Hauser et al., 2011; Chernick
et al., 2019). Peripheral APOE (also referred to as circulating
APOE), produced primarily by liver hepatocytes, remains in
the blood and circulatory system, and is thought to not cross
the blood brain barrier (Liu et al., 2012). A primary role of
circulating APOE is in lipid and cholesterol homeostasis with
APOE functioning as a lipid trafficking protein. The lipid binding
Abbreviations: LOAD, late onset Alzheimer’s disease; VaD, vascular dementia;
HDR, homology directed recombination; VLDL, very low density lipoprotein;
LDL, low density lipoprotein; HDL, high density lipoprotein; NEFA, non-esterified
fatty acids; WGCNA, weighted gene co-expression network analysis; GO, gene
ontology.
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together with the human APOEε4 protein-encoding exons 2–
4 (Figure 1A). Transfected ES cells were screened by Southern
blot to ensure correct targeting. Three clones were identified that
were correctly targeted. ES cells containing the correctly targeted
locus were introduced into albino B6 embryos, and the resultant
chimeric mice were bred with B6 mice. Offspring carrying
the modified locus in the germline were interbred to generate
the homozygous genetically modified genome. All F1 matings
produced normal litter sizes with a Mendelian distribution of the
locus. Heterozygous animals were crossed to FLP recombinase
expression mice (JAX Stock No. 005703) to remove the FRT
site flanked PGK-neo cassette. Mice that no longer contained
the FRT flanked PGK-neo cassette were then backcrossed to B6
at least once to remove the FLP recombinase transgene. SNP
analysis was performed to validate the B6 background. Offspring
that were negative for the FLP recombinase transgene were then
interbred and maintained as APOEε4/ε4 homozygous mice (JAX
Stock No. 000664).
The APOEε3 model was generated using CRISPR/Cas9mediated gene targeting in APOEε4 zygotes (Figure 1A). An
APOEε4 specific sgRNA (GCGGACATGGAGGACGTGCG
CGG; PAM site is underlined) was used to target the human
knock-in allele just downstream of the valine codon that defines
the APOEε4 allele, and a 129 nt single stranded oligonucleotide
(GAGACGCGGGCACGGCTGTCCAAGGAGCTGCAGGCGG
CGCAGGCCCGGCTGGGCGCGGACATGGAGGACGTcTGC
GGCCGCCTGGTGCAGTACCGCGGCGAGGTGCAGGCCA
TGCTCGGCCA) including the CGC->TGC substitution
(bold) to change arginine to cysteine and silent mutation
GTG-GTC (underlined) to prevent re-cutting. Putative founders
were bred to B6 mice for at least four generations and then
interbred to be maintained as APOEε3/ε3 homozygous mice
(JAX Stock No. 029018).
To create experimental cohorts, APOEε3/ε3 mice were crossed
to APOEε4/ε4 mice to generate APOEε3/ε4 mice, which were
then intercrossed to give cohorts of litter-matched mice of all
required genotypes (APOEε3/ε3 , APOEε3/ε4 , and APOEε4/ε4 ).
Three separate cohorts of mice were used in this study. The
first was aged to 2 mos for strain validation including western
blotting. The second was aged to 2 mos for peripheral and cortical
assessments. The third was aged to 1 mo, when half were provided
a running wheel, and subsequently assessed at 4 mos along with
sedentary controls.

and exercise. Lipid profiling was performed on plasma samples
while RNA-seq was performed on the cerebral cortex. Linear
modeling, a mathematical approach widely used for analyzing
transcriptomic data in both humans and mice, was used identify
the contribution of main and interacting factors (genotype,
sex, activity) on the cortical transcriptome (Wang and Brinton,
2016; Belloy et al., 2019; Williams et al., 2020). Results revealed
significant differences between the APOE genotypes in both
the periphery and the cortex supporting our hypothesis that
the APOEε3/ε4 genotype exerts unique effects compared to the
APOEε4/ε4 genotype.

MATERIALS AND METHODS
Mouse Husbandry
All experiments involving mice were conducted with approval
and accordance described in the Guide for the Care and Use
of Laboratory Animals of the National Institutes of Health.
All experiments were approved by the Animal Care and Use
Committee at The Jackson Laboratory. Mice were kept in
a 12/12-h light/dark cycle and fed ad libitum 6% kcal fat
standard mouse chow.

Creation of Humanized Apolipoprotein E
Mouse Strains
Humanized APOE mice were created in collaboration with
the Genetic Engineering Technologies core at The Jackson
Laboratory. The mouse Apoe gene is located on chromosome 7
at 19,696,109–19,699,166. An APOEε4 gene-targeting construct
was made that included 4980 bp of mouse sequence, which
defined the mouse 5’ homology arm including exon 1 of mouse
Apoe, 4292 bp of human APOEε4 sequence including human
protein coding exons 2–4 of the human gene as well as an
additional 1.5 kb of flanking human sequence after the 30 UTR
to include any potential regulatory sequences. Exon 4 contained
sequence that encoded the APOEε4 isoform (nucleotide sequence
for arginine at R130 and R176). The predicted protein sequence
in our humanized APOEε4 mouse model is 317 amino acids
and includes the18 amino acid signal peptide at the N-terminus.
As in all APOE isoforms, the 18 amino acid leader sequence
is cleaved resulting in the mature 299 amino acid protein,
with the amino acids that define APOEε4 located at positions
112 and 158 (Mahley and Rall, 2000; Rohn and Moore, 2017).
A Frt-neo-Frt (FNF) selection cassette was inserted after the
human sequence followed by a Nde1 restriction site (for
ease of Southern screening). The FNF cassette was followed
by 5166 bp of mouse sequence, the 3’ homology arm. The
resulting 14,438 bp synthesized construct was cloned into
pBlight vector using recombineering techniques, producing a
construct called mApoE_hAPOE4_PGKneo_mAPOE for gene
targeting in embryonic stem cells. The APOEε4 gene-targeting
construct was introduced into cultured embryonic stem (ES)
cells of a C57BL/6J (B6) mouse strain by electroporation.
Homologous recombination produced loci that retained all
normal mouse regulatory sequences (plus non-coding exon one)
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Genotyping of Apolipoprotein E Mice

Genotyping to differentiate between APOEε3 and APOEε4 alleles
for our experimental cohorts was performed via ear punch at
1 mo of age. A gel-based PCR assay was used to determine
insertion of the humanized construct (Figure 1B). Primers
included a common forward spanning over intron 1 and exon
2 (AATTTTTCCCTCCGCAGACT), a wild type (WT) mouse
reverse in intron 2 (ACAGCTGCTCAGGGCTATTG), and a
humanized reverse (AGGAGGTTGAGGTGAGGATG). A band
for WT (wild type – mouse control, no humanized insertion)
shows at 244 bp, while the humanized insertion results in a 148 bp
band. To differentiate between the APOEε3 and APOEε4 alleles,
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Sanger sequencing was used to identify CT for APOEε3 , and GC
for APOEε4 , and a double peak signifying the presence of both
APOEε3 and APOEε4 (GT) (Figure 1C).

incubated. Secondary antibodies were also diluted in 5% non-fat
dry milk in 1XPBS + 0.1% Tween20 for 2 h at room temperature.
Membranes were washed again in 5% non-fat dry milk in
1XPBS + 0.1%Tween20 and exposed to Amersham ECL Western
Blotting Detection Reagent (RPN2109, Cytiva, Marlborough,
MA, United States) just prior to digital imaging on the Azure
Biosystems c600 (Azure Biosystems, Dublin, CA, United States).
Actin and APOEε4 were quantified in ImageJ (FIJI).

Validation of Apolipoprotein E
Expression by Western Blotting
Snap-frozen hemispheres were homogenized by hard tissue
homogenizer (USA Scientific, Ocala, FL, United States)
and lysed in 700 mL RIPA buffer (R0278, Sigma, St. Louis,
MO, United States) supplemented with 100× protease and
phosphatase inhibitor reagents (1861281, Thermo Fisher
Scientific, Waltham, MA, United States). Lysates were incubated
for 1 h at 4◦ C before pelleting insoluble proteins by spinning
at 4◦ C, 11,000 × g for 15 min. Protein concentration was
determined by Bradford protein assay (Biorad, Hercules,
CA, United States), according to manufacturer’s instructions.
Samples were mixed with 10× Laemlli buffer (42556.01, Amsbio,
Cambridge, MA, United States), boiled for 10 min, and run
on 12% SDS PAGE gels (456-1044, BioRad) with colorimetric
ladder (RPN800E, GE, Boston, MA, United States). Gels
were transferred to PVDF membranes for immunoblotting
and imaging using an iBlot2 dry blotting system (Thermo
Fisher). Membranes were blocked in 5% non-fat dry milk in
1XPBS + 0.1% Tween20 for 1 h prior to incubating with primary
antibodies diluted in 5% non-fat dry milk in 1XPBS + 0.1%
Tween20 for 1 h at room temperature. Membranes were washed
in 1XPBS + 0.1% Tween20 before incubating with secondary
antibodies diluted in 5% non-fat dry milk in 1XPBS + 0.1%
Tween20. HRP-conjugated secondary antibodies targeting
primary antibody host IgG were incubated at 1 h at room
temperature. Membranes were washed in 1XPBS + 0.1%
Tween20 before digital imaging with SuperSignal West Pico
PLUS chemiluminescent substrate (34579, Thermo Fisher).
Antibodies used include: Pan human APOE (AB947, Millipore,
Burlington, MA, United States); Mouse Apoe (NB100-240,
Novus Biologicals, Centennial, CO, United States); human
APOEε4 (NBP1-49529, Novus Biologicals); Actin (ab179467,
Abcam, Cambridge, United Kingdom).
For APOEε4 quantification, western blots were run as stated
above with modifications. Protein extraction was performed on
snap frozen cerebral cortex tissue in 700–1000 mL RIPA buffer
supplemented with cOmplete Mini Protease Inhibitor Cocktail
(Millipore Sigma, 11836153001), 100 uM PMSF, and 100 µM
Na3V4O. Protein was quantified by Bradford Protein Assay
as stated above. Samples were mixed with 2× Laemmli buffer
and RIPA buffer to dilute all proteins to 100 µg/µl/sample.
Samples were heated for 5 min at 95◦ C, and run on 4–
20% gradient gels (BioRad, 4561096) with Full Range Rainbow
Recombinant Protein Molecular Marker ladder (RPN800E).
Gels were transferred to nitrocellulose membranes (Thermo
Fisher, IB301001) using the iBlot system (Thermo Fisher) for
immunoblotting. Membranes were blocked in 5% non-fat dry
milk in 1XPBS + 0.1% Tween20 for 1 h. Primary antibodies were
diluted in 5% non-fat dry milk in 1XPBS + 0.1% Tween20 and
incubated overnight at 4◦ C moving. Membranes were washed
in 5% non-fat dry milk in 1XPBS + 0.1%Tween20 and then
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Exercise by Voluntary Running
At first, mice were group housed (two or three per pen) and
were provided access to low profile saucer wheels (Innovive Inc.)
24 h a day from 1 mo to 4 mos. Sedentary mice were not
provided access to running wheels. At 4 mos, just prior to harvest,
mice were separated and individually housed with a trackable
low-profile running wheel (Med Associates Inc.) or no wheel
access. Rotations per minute during lights out (12 h, 6:00 pm –
6:00 am) were quantified. This time period was used as it is when
mice are naturally awake and active. Running wheel rotations
were measured in 1-min bins to allow for distance traveled
(sum of rotations) calculated per mouse each night. Average
rotations were calculated per mouse. Average speed while active
was calculated by isolating the minute intervals where activity was
measured (>0) and averaging the number of rotations for the
minutes active. Percent of time at each speed was calculated by
totaling the number of minute bins that mice ran between 0, 1–30
rotations, 31–70 rotations, 71–100 rotations, and 100+ rotations
and dividing by the total amount of minutes tracked. Any nights
that had fewer than 700 min tracked were excluded from analysis.

Harvesting, Tissue Preparation and
Blood Lipid Profiling Assessment
All mice were euthanized by intraperitoneal injection of a
lethal dose of Ketamine (100 mg/ml)/Xylazine (20 mg/ml)
and blood was collected in K2 EDTA (1.0 mg) microtainer
tubes (BD, Franklin Lakes, NJ, United States) through approved
cardiac puncture protocols. Mice were perfused intracardially
with 1XPBS. Brains were carefully dissected then hemisected
sagittally, and the cortex (Ctx) was then carefully isolated and
snap frozen in solid CO2 for RNA-sequencing and cholesterol
profiling. Blood was kept at room temperature for at least 30 min
to prevent clotting, and then centrifuged at 21◦ C for 10 min
at 5000 rpm. Plasma was carefully collected. Plasma and brain
lipid concentrations were characterized on the Beckman Coulter
AU680 chemistry analyzer.

RNA Extraction, Library Construction,
RNA Sequencing, and RNA Sequencing
Quality Control
RNA sequencing (RNA-seq) was performed by The Jackson
Laboratory Genome Technologies Core. RNA extraction
involved homogenization with TRIzol (Invitrogen, Waltham,
MA, United States) as previously described (Soto et al., 2015).
RNA was isolated and purified using the QIAGEN miRNeasy
mini extraction kit (Qiagen, Hilden, Germany) in accordance
with manufacturer’s instructions. RNA quality was measured via
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FIGURE 1 | Creation and validation of APOE allelic series. (A) Schematic of human APOE allele insertion at the mouse Apoe locus on chromosome 7. Exon 1
remained unchanged (mouse) and exons 2–4 were replaced with human APOEε4 sequence through homology directed repair (HDR). The neomycin cassette was
removed (* indicated by asterisk) through Flp-Frt breeding (Flp-Frt sites not shown). The APOEε3 SNP was changed through CRISPR mediated endonuclease
activity. Critical amino acids differing between APOEε4 and APOEε3 noted in red. (B) PCR based assay to identify humanized APOE insertions at exon 2 vs. WT
mouse Apoe (no insertion) at exon 2. (C) Sanger sequencing to distinguish APOEε3 and/or APOEε4 alleles. (D) Western blotting revealed significant differences in
APOEε4 levels between genotypes.

the Bioanalyzer 2100 (Agilent, Santa Clara, CA, United States)
and poly(A) RNA-seq sequencing libraries were compiled by
TruSeq RNA Sample preparation kit v2 (Illumina, San Diego,
CA, United States). Quantification was performed using qPCR
(Kapa Biosystems). RNA-seq was performed on the HiSeq 4000
platform (Illumina) for 2 × 100 bp reads for a total of 45 million

Frontiers in Aging Neuroscience | www.frontiersin.org

reads according to the manufacturer’s instructions. Quality
control for each sample was completed using NGSQCToolkit
v2.3 which removed adaptors and trimmed low quality bases
(Phred < 30) (Patel and Jain, 2012). To quantify gene expression
of the trimmed reads, we used RSEM v1.2.12 which uses Bowtie2
v2.2.0 for alignment of these reads (Langmead et al., 2009). We
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used a custom mouse genome including mm-10 based upon the
B6 reference genome, with the addition of the human APOE
gene for continuity.

Weighted Gene Co-expression Network
Analysis
Weighted gene co-expression network analysis required the
WGCNA package by Horvath and Langfelder (Langfelder and
Horvath, 2008, 2012). Normalized and variance transformed
data (vst) without outliers was used to build weight gene coexpression networks. First, all samples passed the function
goodSamplesGenes to check for incomplete sample data. Samples
were clustered to identify outliers using hierarchical clustering;
two samples were excluded from further analysis. Next, the
soft-thresholding power (b) was chosen by calculating scalefree topology through the relationship between power and scale
independence which resulted in a softPower of 5. Then 18
modules were clustered based upon minModuleSize = 30, and
a mergeCutHeight = 0.4. These values were chosen based off
previous studies with similar methods to achieve non-redundant
smaller modules (Zhao et al., 2020). Module eigengenes for each
module were identified and the correlation to sex, genotype, and
activity was computed. The p values were then corrected for
multiple testing both within and across terms by calculating false
discovery rates. Genes in each module were annotated by using
the AnnotationDbi package (Hervé Pagès et al., 2020). Module
membership (module eigengene correlated with gene expression)
was regressed against gene significance (the correlation between
the linear model predictor term and each individual gene) to
identify highly correlated modules (Pearson correlation). Genes
in a module were processed through clusterProfiler to identify
functional enrichment.

Linear Modeling and Functional
Enrichment
Genes were filtered by (1) removing all genes that did not vary
in expression (gene count change across all samples was 0) and
(2) removing all genes that did not have at least five reads in 50%
of the samples. Remaining genes were normalized using DEseq2
(Love et al., 2014). Variance stabilizing transformation (vst) was
then performed. Principal component analysis (PCA) identified
three outliers from the 2 mo dataset, and five outliers from the
4 mo dataset which were excluded from further analysis. APOE
genotype will be referred to as ‘genotype.’ A linear model was used
on the normalized counts to identify genes significantly fit by the
predictors of our model: sex, genotype, and sex-genotype in the
2 mo dataset, and sex, genotype, activity, and genotype-activity
in the 4 mo dataset. Reference data in the model were ‘female
APOEε3/ε3 ’ for 2 mo and ‘female sedentary APOEε3/ε3 , for 4 mo
data. The linear model was performed on 18,402 genes for 2 mos
and on 18,987 genes for 4 mos. Nominal significant genes were
identified per predictor term (sex, genotype, etc.) based upon
Pr(>|t|< 0.05). Functional enrichment for each linear model
predictor term was performed using the clusterProfiler package
with p < 0.10 to determine significant GO terms (Yu et al.,
2012). Bonferroni Hochberg (BH) conditions were chosen for
pAdjustMethod. Background lists consisted of all genes prior to
significant geneset filtering.

APOEε3/3

Comparison of
Samples to Zhao et al.

and

Neuronal Counts

APOEε4/4

To quantify neuronal cell number, 4 mo female sedentary mice
were evaluated as previous studies would suggest they would
be the most susceptible to neuronal loss. Two of each genotype
(six samples total) were stained in replicates of three (three
brain slices) and then evaluated for NEUN+ DAPI+ cells in
the cortex above the CA1 in the hippocampus. Brains were
cryosectioned at 20 mm onto slides. Sections were blocked for 1 h
in 2%PBT + 10% Normal Goat Serum. Primary antibody NEUN
(abcam, ab104225) was diluted in 2% PBT + 10% Normal Goat
Serum and kept at 4◦ C overnight. Slides were washed 3 × 10 min
in 2% PBT. Secondary antibody (goat anti rabbit 488) was diluted
in 2%PBT and kept for 3 h at room temperature. A representative
cortical section was imaged on a Leica SP8 confocal microscope
at 1 um step size for 20 um. Images were quantified identically
with the spots feature through IMARIS software for NEUN+
and DAPI+ cells.

Previously published cortical transcriptional data was accessed
through the AD Knowledge Portal. Gene expression from Zhao
et al. (2020) utilized conditional quantile normalization (CQN)normalized log2RPKM values. Samples from 3 mo mice were
filtered for, and then used for PCA clustering. To match previous
publications, no scaling or centering was used in this PCA. Linear
modeling was run on 19,120 genes across 32 samples with factors
for sex, genotype, and sex-genotype. Significant genes were
identified per predictor term (sex, genotype, etc.) based upon
Pr(> | t| < 0.05). Functional enrichment for each linear model
predictor term was performed using the clusterProfiler package
with p < 0.05 to determine significant GO terms (Yu et al., 2012).

Cell Type Specific Enrichment
Statistical Analysis

Publicly available cell type gene expression was downloaded from
the brainrna-seq.org dataset generated by the Barres laboratory
(Zhang et al., 2014, 2016). Significant genes from linear model
results from 2- and 4- mo data were cross referenced to this
dataset. Some genes in our datasets were not found in the
brainRNA-seq dataset and were excluded. Number of genes per
cell type was expressed as a percentage of a specific cell type
divided by all genes that were able to be cross referenced for the
linear model predictor terms.
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Statistical analysis for 2 mo biometric data including cholesterol
composition, triglyceride, unfasted glucose, and non-esterified
fatty acids (NEFA) were calculated by two-way ANOVA
(interactions tested: sex-genotype, main effects: sex, genotype),
and a post hoc Tukey test in GraphPad Prism v7.0a. Outliers
were identified by ROUT (Q = 1.0%) using GraphPad Prism
v7.0a. Statistical analysis for 4 mo biometric data was performed
by three-way ANOVA (interactions tested: sex-genotype-activity,
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component analysis (PCA) showed clear separation between
the sexes. There was no separation based on APOE genotype
(Figures 3A,B) which agreed with previous studies (Zhao
et al., 2020). Using APOEε3/ε3 as the ‘control’ genotype, linear
modeling identified genes that varied as a function of sex, APOE
genotype, and the interaction between sex and APOE genotype
(Figure 3C, see the section “Materials and Methods”). Only 127
genes were in common between the 487 APOEε3/ε4 and the
518 APOEε4/ε4 genes (Figure 3D). GO terms enriched for the
360 unique APOEε3/ε4 genes included ‘regulation of hormone
levels,’ ‘regulation of hormone secretion,’ and ‘insulin secretion’
(Figure 3E and Supplementary Figure 7). Hormone signaling,
particularly in the glucose/insulin pathway, is disrupted in
APOEε4 individuals and can increase the severity of dementia
(Peila et al., 2002; Irie et al., 2008). No GO terms were
enriched for either the 127 intersection genes or the 391 genes
unique to APOEε4/ε4 , suggesting multiple unrelated processes
may be more subtly affected. Interestingly, APOEε4/ε4 unique
genes included angiogenesis-related Acvrl1, Ang, Eng, Vegfc, and
cell adhesion-related Fermt3, Itga2b, Itga5. Ang can function
by endothelial nuclear translocation to stimulate endothelial
angiogenesis, while Vegfc is involved in vascular permeability
(Moroianu and Riordan, 1994; Gao and Xu, 2008; Tammela et al.,
2008; Miyake et al., 2015; Nagai and Minami, 2015; Apte et al.,
2019). Both Itga2b and Itga5 are receptors for fibrinogen and
fibronectin, involved in the blood clotting cascade, while Fermt3
is involved in leukocyte adhesion to endothelial cells (Varner
et al., 1995; Oksala et al., 2015; Botero et al., 2020). RNA in situ
hybridization (Allen Brain Atlas) and single cell sequencing of
vascular-related cells confirm both Acvrl1 (activin A receptor
like Type 1) and Eng (endoglin) are expressed by vascular cells,
including endothelial cells (Supplementary Figures 5, 6; Lein
et al., 2007; Vanlandewijck et al., 2018).
Cell type analysis revealed that while the APOEε3/ε4 unique
genes are expressed in multiple cell types, the majority of
these genes are expressed by endothelial cells and astrocytes. In
contrast, the majority of APOEε4/ε4 unique genes are expressed
by neurons (Figure 3F). This further supports subtle but unique
effects of APOE genotype to the cerebral cortex at a young age
that may predispose for AD and dementia later in life.

genotype-activity, sex-activity, sex-genotype, main effects tested:
sex, activity, genotype) followed by a TukeyHSD post hoc test in
R v1.2.1335. Terms were considered significant if p < 0.05. Post
hoc tests were used to determine differences between genotypes
per sex, significant effects between genotypes and sexes were not
reported (i.e., female-sed-APOEε3/ε4 to male-sed-APOEε3/ε3 ).
All weight and biometric data included groups of 5–16 mice per
sex/genotype/activity. Transcriptional profiling was performed
on groups of six mice per sex/genotype/activity. Details of
statistical analyses of linear modeling, functional enrichment, and
WGCNA data are provided above.

RESULTS
Creation of Humanized APOEε3/ε3 ,
APOEε3/ε4 , and APOEε4/ε4 Mice

Humanized APOEε3/ε3 and APOEε4/ε4 mice were created on
C57BL/6J (B6) mouse strain using a similar design to that
described previously (Supplementary Figure 1A, see the section
“Materials and Methods”) (Sullivan et al., 1997; Knouff et al.,
1999). Briefly, exons two through four of the mouse Apoe gene
were replaced by sequence encoding the equivalent region in
human the APOEε4 gene through homologous directed repair
(HDR) (Figure 1A and Supplementary Figures 1B,C). The
APOEε3 allele was produced by CRISPR-Cas9 of APOEε4/ε4
mice (Figures 1B,C). A PCR-based assay combined with Sanger
sequencing was used to confirm humanized APOE alleles
(Figures 1B,C). Protein was confirmed by western blotting with
human APOE protein present in all humanized APOE mice.
APOEε4 protein only detectable in APOEε3/ε4 and APOEε4/ε4
mice in a relative abundance of 0.38 and 0.49, respectively
(Figure 1D and Supplementary Figures 2,3).
To evaluate whether APOEε4 dosage affected body weight
and circulating lipids, two translatable biometric measurements,
litter-matched male and female APOEε3/ε3 , APOEε3/ε4 and
APOEε4/ε4 mice were assayed at 2 mos. As expected, body weight
was significantly different between sexes, with males weighing
more than females. However, body weight was not affected
by APOE genotype (Figure 2A). Total cholesterol, HDL, and
unfasted glucose levels in plasma showed a significant main effect
of sex, with males showing higher concentrations than females
(Figures 2B,D,F). There was a significant interaction between sex
and APOE genotype for LDL with the sexes showing differing
trends in APOEε3/ε4 mice (Figure 2C). Plasma triglyceride levels,
and brain total cholesterol, HDL, and LDL concentrations did
not show an effect of sex or APOE genotype (Figure 2E and
Supplementary Figure 4).

Sex and Physical Activity, but Not
Apolipoprotein E Genotype Influence
Peripheral Cholesterol Composition at
4 Months
Physical activity, especially running, has been widely considered
a prevention, reducing risk for age-dependent cognitive decline
and dementia. However, exercise may not prevent dementia
in all individuals. We hypothesized that this may be due
in part to genetics. To begin to test this we determined
whether the effects of exercise are influenced by APOE
genotype in young mice. Litter-matched male and female
APOEε3/ε3 , APOEε3/ε4 and APOEε4/ε4 mice were given access
to a voluntary running wheel for 12 weeks from 1 mo to
4 mos (Figure 4A, see the section “Materials and Methods”).
There was expected variation between mice for amount of

Cortical Transcriptional Profiling Reveals
Unique Effects of APOEε3/ε4 Genotype at
2 Months

We hypothesized that compared to APOEε4/ε4 , the APOEε3/ε4
genotype may differentially modulate cerebral processes. To
assess this, RNA-seq was performed on cortical tissue collected
from litter-matched male and female mice at 2 mos. Principal
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FIGURE 2 | Plasma cholesterol composition affected by sex, but not APOE genotype, at 2 months. (A) Weight (grams, g) at harvest in both male and female APOE
mice showed expected significant sex differences across all genotypes. (B) Total plasma cholesterol concentration revealed a significant effect of sex. (C) Low
density lipoprotein (LDL) concentration showed a significant interactive effect between APOE genotype and sex, as well as a main effect of sex. (D) High density
lipoprotein concentration (HDL) showed a significant effect of sex. (E) Triglyceride concentration showed no effect by APOE genotype or sex. (F) Unfasted glucose
showed a significant sex effect. Significant ANOVA results are stated under the title of the graph, significant Tukey post hoc results are shown on graph between
significant groups. All significance data can be found in Supplementary Table 1.

time spent running and there were no differences in average
rotations or running speed between APOE genotypes for both
sexes, indicating activity may be compared across genotypes
as it is not a confound (Supplementary Figures 8A–F).
As has been shown before, female mice tended to run
farther than male mice (Foley et al., 2019). As expected,
there was a significant difference in weight between sexes
at 4 mos, but there were no differences between the APOE
genotypes or running and sedentary groups for either sex
(Figures 4B–D).
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Apolipoprotein E genotype did not significantly influence total
cholesterol, LDL or HDL which agrees with previous findings
in other APOE mouse models (Knouff et al., 1999; Mann et al.,
2004). There was also no effect of APOE genotype on unfasted
glucose, or NEFA concentrations in the plasma (Figures 4E–
G,I,J). However, there was an effect of sex for total cholesterol,
LDL, HDL and unfasted glucose levels, with males having higher
total cholesterol, HDL, and unfasted glucose and lower LDL
than females (Figures 4E–G,I). There was also an interaction
between sex and activity for total cholesterol and HDL, suggesting
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FIGURE 3 | Cortical transcriptome analysis revealed unique functional enrichment for the APOEε3/ε4 genotype at 2 months. (A) PCA showed distinct clusters of
male and female samples. (B) PCA showed samples do not cluster by APOE genotype at two mos. (C) Number of significant genes for each linear model predictor
term (p < 0.05). (D) Number of significant genes unique to 2-month APOEε4/ε4 and APOEε4/ε4 when compared to APOEε3/ε3 , as well as the number of significant
genes intersecting both lists. (E) Functional enrichment of the 360 significant genes (p < 0.10) unique to APOEε3/ε4 compared to APOEε3/ε3 . (F) Percentage of
genes expressed by cell type according to the BrainRNAseq dataset.
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FIGURE 4 | APOE genotype did not affect weight or cholesterol composition at 4 months. (A) Schematic of experiment and timeline. (B,C) Weights of male (B) and
female (C) mice over the course of the running experiment. (D) Weight at harvest of both male and female mice across APOE genotypes showed a significant effect
of sex. (E) Plasma total cholesterol concentrations revealed a main effect of sex and an interactive effect between sex and activity. (F) LDL concentration revealed a
significant effect of sex. (G) HDL concentration revealed a significant effect of sex and interactive effect between sex and activity. (H) Triglyceride concentrations
revealed a significant effect of APOE genotype and an interactive effect between sex, activity and APOE genotype. (I) Unfasted glucose concentrations revealed an
effect of sex. (J) Non-esterified fatty acid (NEFA) concentrations revealed no significant effects. Significant ANOVA results are stated under the title of the graph,
significant Tukey post hoc results can be found in Supplementary Table 2.
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FIGURE 5 | Significant genes unique for APOEε3/ε4 genotype showed functional enrichment for ‘extracellular matrix’ and ‘response to wounding’ at 4 months. (A,B)
Average number of rotations per night during the dark cycle for female (A) and males (B) across all APOE genotypes for the six mice per group that were selected
for RNA-seq. Mean is representative of all mice, including those that were not sequenced (see also Supplementary Figure 8). (C) Number of significant genes per
each linear model predictor term. Red arrows highlight APOEε4/ε4 and APOEε3/ε4 terms used in panel (D). (D) Number of significant genes unique to APOEε3/ε4
when compared to APOEε3/ε3 , and APOEε4/ε4 compared to APOEε3/ε3 , as well as the number of significant genes intersecting both groups. (E) Functional
enrichment of the 253 genes unique to APOEε3/ε4 compared to APOEε3/ε3 (left), 374 genes unique to APOEε4/ε4 compared to APOEε3/ε3 (right) and 74
intersection genes between the two groups (middle) (p < 0.05).
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FIGURE 6 | WGCNA confirmed functional enrichment of GO terms relating to extracellular matrix and morphogenesis is affected by APOE genotype. (A) Heatmap of
module correlation and FDR values for sex, APOE genotype, and activity (p < 0.10). (B) Eigengene dendrogram of each module and sex, APOE genotype and
activity. Y axis is a measure of dissimilarity. (C,D) Gene significance regressed against module membership to show correlation and significance for the yellow (C) and
greenyellow (D) modules for APOE genotype. (E) Functional enrichment of the genes in the greenyellow module which is significant for APOE genotype (p < 0.05).

the effect of activity on plasma cholesterol may be sex-specific
at a young age (Figures 4E,G and Supplementary Table 2).
There was a significant sex-activity-genotype interaction on
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triglyceride concentration (Figure 4H). Across total cholesterol
and HDL concentration, there was an interesting sex-activity
interaction, with activity appearing to have differential effects
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55 genes upregulated, although the degree of regulation (β
value) was different.
While many cell types can contribute to the extracellular
matrix (ECM)- and coagulation-related pathways, endothelial
cells contributed to 33% of the unique genes that were in the
APOEε3/ε4 dataset (Supplementary Figure 12B). The cell types
enriched for intersection genes included both oligodendrocyte
precursor cells, as well as microglia (Supplementary Figure 12B).
No specific cell types appeared to be responsible for APOEε4/ε4
unique genes. While there is no single cell type contributing to the
APOEε4/ε4 -dependent transcriptional differences, endothelial
cells may be critical drivers of transcriptional differences in
APOEε3/ε4 mice (Supplementary Figure 12B). Interestingly, our
data for APOEε4/ε4 -specific changes only minimally overlapped
with previous studies (Supplementary Figure 13), differences
likely due to dissimilarities in study design and environment
(Zhao et al., 2020). The APOEε3/ε4 genotype was not studied
previously (Zhao et al., 2020).
In examining genes unique to APOEε3/ε4 genotype and
expressed by endothelial cells we observed several annexin
genes. Both Anxa1 and Anxa2 contributed to the enrichment
terms ‘extracellular matrix,’ ‘response to wound healing,’ and
’coagulation.’ Anxa2 has direct effects on the plasminogen/fibrin
clotting response (Supplementary Figure 12C; Ling et al., 2004).
While we expected a linear increase in gene expression with
increasing APOEε4 gene dose, for endothelial-expressed Anxa1,
Anxa2, and Anxa3, there was a significant increase in the
APOEε3/ε4 genotype when compared to APOEε3/ε3 , but not a
significant increase in the APOEε4/ε4 genotype when compared
to APOEε3/ε3 . This pattern suggests that expression of some
genes was differentially affected by the combination of the
APOEε3 and APOEε4 allele.
To determine whether exercise effects the cortex in an APOE
genotype-specific manner, we compared the genes for activityAPOEε3/ε4 with activity-APOEε4/ε4 . Only 17% of activityAPOEε3/ε4 , and 12% of activity-APOEε4/ε4 genes overlapped
(Supplementary Figure 14A). Three intersection genes enriched
for ‘anoikis’ (consisting of Src, Tfdp1 and Bmf ), suggesting a
common cell death response between genotypes in response to
activity (Supplementary Figures 14B,C). Together, these data
show that exercise and APOE genotype do not appear to overtly
interact on a transcriptional level in 4 mo mice.

per sex. In total cholesterol and HDL there was an overall
decrease in lipid concentration with running in males, however
in females, there was an overall increase in these lipids. These
results suggest that activity may have different effects on
circulating lipid concentrations due to sex-based differences.
Together, the effects of exercise on cholesterol composition
were subtle and not influenced by APOE genotype, whereas
triglyceride concentrations were influenced by sex, activity, and
APOE genotype.

Unique APOEε3/ε4 Genes Enrich for
Extracellular Matrix (ECM)- and
Coagulation-Related Terms

To determine whether the effects of APOEε4 on the brain are
modified by running in an APOE genotype-specific manner,
cortical transcriptional profiling and linear modeling were
performed (see the section “Materials and Methods”). Genes
significantly associated with sex, APOEε3/ε4 , APOEε4/ε4 , activity
and the interactions were identified (Figures 5A–C and
Supplementary Figures 8C,D; Foley et al., 2019). The largest
number of genes were significant for sex which enriched for
‘response to interferon beta,’ ‘response to virus,’ and ‘innate
immune response,’ including known AD and dementia risk genes
Clu, and Plgc2, suggesting a difference in immune function
between the sexes (Supplementary Figure 10). There was no
enrichment for the 540 genes significant for activity, suggesting
multiple processes affected. Of the 540 genes, Cx3cr1 and
Csf1r were significant and have been previously implicated
in maintaining microglia homeostasis, suggesting microglia
response may be affected by activity across APOE genotypes
(Keren-Shaul et al., 2017).
Of the 327 genes significant for APOEε3/ε4 and the
448 genes significant for APOEε4/ε4 only 74 intersected
(22% from APOEε3/ε4 genes, 17% from APOEε4/ε4 genes)
(Figure 5D) which was similar to our findings at 2 mos.
Of the 253 genes unique for APOEε3/ε4 63 genes were
downregulated (negative β value) and 190 were upregulated
(β value). The 253 APOEε3/ε4 unique genes enriched for
GO terms such as ‘extracellular matrix,’ ‘collagen-containing
extracellular matrix,’ and ‘wound healing’ (Figure 5E and
Supplementary Figure 12A). The 374 APOEε4/ε4 unique genes
enriched for ‘branching morphogenesis of an epithelial tube,’
‘chemeotaxis’ and ‘taxis,’ including genes such as Gli3, Cx3cr1,
and Ccr1 (Figure 5C and Supplementary Figure 11A). Of
the 374 genes there were 183 downregulated and 191 genes
upregulated, indicated by a negative and a positive β-value,
respectively. The 74 intersecting genes enriched for ‘MHC
protein complex’ and ‘BMP receptor binding’ including genes
associated with these GO terms included Bmp5, Bmp6, and
Spp1 (Supplementary Figure 11B). BMP (bone morphogenetic
protein) signaling has been previously implicated in vascular
development and more importantly, abnormal BMP protein
expression can lead to vascular dysfunction, suggesting another
pathway by which the APOEε4 allele influences AD and
dementia pathologies (Garcia de Vinuesa et al., 2016). Of
these 74 intersecting genes, 19 genes were downregulated and
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Weighted Gene Co-expression Network
Analysis Confirms Apolipoprotein E
Genotype-Specific Effects but Shows No
Genotype by Activity-Specific Effects
While linear modeling indicated subtle changes at the gene
level, to ensure these changes were robust we employed a
second approach, weighted gene co-expression network analysis
(WGCNA) on the same 4 mo dataset. We used WGCNA to
create modules of groups of genes across the entire dataset,
thus reducing complexity of the large number of input genes to
produce biologically relevant modules. This method differs from
linear modeling by grouping genes into modules, including genes
that may not be significant on the gene level, but still contribute
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new humanized APOE mouse models and data help to facilitate
these mechanistic studies.
Our results indicate that APOE genotype did not affect total
cholesterol, HDL, or LDL levels in the blood at 2 and 4 mos. These
data confirm reports using other humanized APOE models,
where no APOE genotype differences were observed in plasma
total cholesterol, HDL, or triglyceride in female mice between
2 and 5 mos (Knouff et al., 1999; Mann et al., 2004). It is of
note that there are well-established differences in cholesterol
composition between humans and mice due, at least in part, to
a lack of cholesterol ester transfer protein (CETP) in mice which
aids in the transfer of cholesterol esters depending on triglyceride
concentration status (Davidson, 2010). This inability to properly
transfer cholesteryl esters and triglycerides results in higher HDL
and lower LDL levels in mice (Mabuchi et al., 2014). Cholesterol
composition in heterozygous APOE genotypes throughout aging
are still necessary, as this is when APOE genotype differences are
reported to become more prominent.
Human studies have reported differences in triglycerides due
to APOE genotype, with an increase in circulating triglyceride
levels for each copy of APOEε4 . In our study, there was no APOE
genotype effect on triglyceride levels at 2 mos, but differences
were observed at 4 mos (Huang, 2010; Belloy et al., 2019). Data
from other humanized APOE mice agreed with our 2 mo findings
showing no significant difference in triglyceride concentrations
between APOEε3/ε3 and APOEε4/ε4 mice (Knouff et al., 1999;
Mann et al., 2004). While these findings indicate that APOE
genotype does not affect lipid homeostasis at an early age,
genotype-specific differences may come apparent at older ages –
studies that are ongoing.
The APOEε3/ε4 genotype uniquely affected the cortical
transcriptome at 2 and 4 mos (using APOEε3/ε3 as reference
in our linear model). At 2 mos, genes unique for APOEε3/ε4
enriched for ‘regulation of hormone levels’ and ‘insulin
secretion.’ At 4 mos, genes unique for APOEε3/ε4 enriched for
‘extracellular matrix,’ ‘collagen-containing extracellular matrix,’
and ‘blood coagulation,’ suggesting that the cerebrovasculature
may be compromised. Our cell type analysis showed a greater
contribution by endothelial cells in APOEε3/ε4 for these
cerebrovascular terms, however this data is not inclusive of all
cells in the cerebrovasculature, such as pericytes which have been
shown to be impacted by APOE genotype (Montagne et al., 2020).
Overall, these data supported our hypothesis that the APOEε3/ε4
risk genotype confers unique effects compared to APOEε4/ε4 and
signify the need to better understand the effect of heterozygous
APOE genotypes and how these differences may play a role in
risk for dementia. Linear modeling is commonly used to identify
significant changes to biological systems, and this is the case for
the genotype differences identified in this study.
A previous study using other humanized APOE mice sought
to examine early transcriptome and proteome changes in
the APOE ε4/ε4 , APOE ε3/ε3 and APOE ε2/ε2 mouse cortex
(Zhao et al., 2020). Analysis of their data with our linear
modeling approach identified differences in the number of
significant genes found between the two studies. We predict these
differences are more likely due to study design, mouse cohort
generation, mouse husbandry, environment, tissue harvesting,

to the coordination of a significant biological process. Nineteen
modules were identified, and two modules were significantly
correlated with sex (grey60, gray), two modules significantly
correlated for genotype (yellow and greenyellow), and six
modules significantly correlated for activity (cyan, lightgreen, tan,
brown, pink, and red) (Figure 6A, see the section “Materials
and Methods”). No modules were significant across multiple
terms. Module eigengenes were calculated and dissimilarity
plotted to visualize the relationship between modules and
terms (Figure 6B). Both the yellow and greenyellow modules
were significantly correlated to APOE genotype (Figures 6C,D).
The yellow module showed no enrichment, however the
genes in the greenyellow module enriched for ‘extracellular
matrix,’ ‘embryonic morphogenesis,’ and ‘collagen-containing
extracellular matrix’ and showed distinct differences between
APOEε3/ε3 and both APOEε3/ε4 and APOEε4/ε4 (Figure 6C and
Supplementary Figure 14D). Confirming our previous findings,
these data suggest that APOE genotype affects the extracellular
matrix, collagen, and morphogenesis (Figure 4).
The cyan and tan modules were significantly correlated
for activity, and cyan enriched for ‘ensheathment of neurons,’
‘myelination,’ and ‘gliogenesis,’ while the tan module enriched for
‘skeletal muscle cell differentiation,’ and ‘skeletal muscle organ
development’ (Supplementary Figures 15A–D). However, no
modules were significant for both APOE genotype and activity.
These data support our previous findings by linear modeling
that suggest the effects of exercise on cortical gene expression
are not significantly impacted by APOE genotype, at least
at this young age.

DISCUSSION
In this study, we demonstrated the importance of including the
APOEε3/ε4 genotype to study the biology of APOE. APOEε3/ε4
is more common than APOEε4/ε4 across Caucasian, African
America, Hispanic, and Japanese populations, which means there
is a stark disconnect between genotypes evaluated in current
mouse models to those present in human studies (Farrer et al.,
1997). In human studies, the rarity of APOEε4/ε4 individuals
results in a clustering of both APOEε3/ε4 and APOEε4/ε4
(often referred to as ‘APOEε4 +’ or ‘APOEε4 carriers’). These
studies have been instrumental in understanding the effect of
APOEε4 on cognitive health trajectories in humans, finding
key biomarkers (e.g., soluble PDGFRβ) that are APOEε4 +
carrier specific, however the next step requires determining
whether this is relevant for APOEε3/ε4 and APOEε4/ε4 similarly
(Montagne et al., 2020). While informational, these strategies
obfuscate differences between the two risk genotypes with the
APOEε3/ε4 effect likely dominating the findings. In contrast,
the vast majority of mouse studies performed to date primarily
contrast the APOEε4/ε4 genotype with the APOEε3/ε3 genotype.
Our transcriptome profiling approach predicts the APOEε3/ε4
genotype exerts unique effects on the cortex, therefore supporting
more studies in mouse models to understand mechanisms by
which the APOEε3/ε4 genotype increases risk for ADRDs. Our
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and sequencing platform rather than inherent differences
between the humanized APOE models. However, future studies
are necessary to compare the available humanized APOE models
under the same conditions.
APOEε4 carrier females are at a greater risk dementia than
their male counterparts. Postmenopausal females account for
over 60% of AD cases (Riedel et al., 2016; Mosconi et al., 2018).
In women, one APOEε4 allele causes an increase in dementia risk
equivalent to two APOEε4/ε4 alleles in men (Riedel et al., 2016).
Our study supports that sex-specific APOEε4 effects begin early
in adolescence/adulthood and would be predicted to exacerbate
dementia pathophysiology later in life. When examining the
effect of sex by genotype interactions for APOEε4 status at
2 mos and then 4 mos, there were more genes significant for
sex-APOEε4/ε4 , than sex-APOEε3/ε4 . These data indicate that
APOE genotype interacts with sex-specific characteristics even at
younger ages (as early as adolescence) to differentially predispose
females and males to dementia later in life.
The molecular effects of exercise in the context APOE
genotype are not known. With previous studies suggesting
that up to a third of LOAD cases may be prevented by
physical activity, it is of the utmost importance to understand
the interactions between genetic risk and exercise (Norton
et al., 2014). To elucidate the effects of exercise on dementia
related pathology, most exercise-based murine studies utilized
amyloidogenic models relevant to AD or middle cerebral
artery occlusion models of VaD (Yuede et al., 2009; Otsuka
et al., 2016; Choi et al., 2018; Khodadadi et al., 2018; Rezaei
et al., 2018; Zhang et al., 2018). The few studies that have
determined whether exercise is beneficial in the context
of APOE utilized mostly APOE knockout mice (Nichol
et al., 2009; Soto et al., 2015; Di Cataldo et al., 2016;
Jakic et al., 2019; Zheng and Cai, 2019; Chaudhari et al.,
2020). Our experimental design suggests exercise affects
young mice in subtle ways that are not greatly impacted by
APOE genotype, however aging studies may reveal greater
APOE and exercise interactions. Linear modeling identified
genes relevant to ECM health, the blood clotting cascade,
development, and microglia homeostasis, all processes that
play a role in modulating risk for ADRDs. Separately,
WGCNA identified a module that correlated with activity
which contained genes that enriched for myelination and
gliogenesis (Supplementary Figure 15C). Previous studies
have shown that voluntary exercise impacts myelination
by increasing the proliferation oligodendrocyte precursor
cells and mature oligodendrocytes in the motor cortex
(Zheng et al., 2019).
Surprisingly, in our study, there were no significant functional
enrichment terms for the genes unique to activity-APOEε3/ε4 and
activity-APOEε4/ε4 . It will be important to understand whether
longer term exercise paradigms are impacted by APOE genotype.
APOEε4 exhibits harmful effects on the brain, predisposing
for AD and cognitive decline. In general, few studies have
determined whether long-term exercise is beneficial in the
context of APOE risk genotypes. Exercise may mitigate or
exacerbate APOEε4 -dependent risk depending on the specific
biological process considered.
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CONCLUSION
These novel APOE models increase the ability to elucidate the
mechanisms by which heterozygous APOE genotypes increase
risk for AD and dementia. Our study predicts important
unique effects of the APOEε3/ε4 genotype on AD-relevant
phenotypes including biometrics and cortical gene expression.
These differences need to be better understood to properly
determine whether the mechanisms increasing risk for diseases
such as AD and related dementias in those carrying one APOE
ε4 allele are different from those carrying two, particularly as
differential APOE genotype effects may be exacerbated at older
ages. This work supports that research and therapies need to
account for the impact of APOE ε4 allele dosage on ADRD
risk and pathology.
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